AUG 10, 2026 · PHASE 1 TRIAL
A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in People Living With Overweight or Obesity
ClinicalTrials.gov
This is a Phase 1 first-in-human safety and tolerability study with no results yet posted; the registry record describes planned conduct only.
Reported
Estimated enrollment35
PhasePHASE 1
Primary outcome assessment periodUp to 113 days